OR6C76: A Potential Drug Target and Biomarker (G390326)

OR6C76: A Potential Drug Target and Biomarker

OR6C76, also known as olfactory receptor family 6 subfamily C member 76, is a G protein-coupled receptor (GPCR) that is expressed in the olfactory system of the human nose. GPCR is a family of transmembrane proteins that play an important role in sensory perception, including the sense of smell. OR6C76 is one of the many GPCR genes that have been identified and studied for their potential drug-targeting properties.

The olfactory system is the primary sense of smell that allows humans to perceive the world around us. The sense of smell is mediated by the Olfactory receptors, which are located in the olfactory bulbs of the brain. These receptors are sensitive to various chemical molecules that are released by the body, such as scents. When a scent is detected, the Olfactory receptors send signals to the brain, which are then interpreted as the smell.

OR6C76 is one of the genes that encodes the Olfactory receptor family member 6 subfamily C. This subfamily is characterized by the presence of a specific extracellular domain, known as the C-terminus, which is responsible for the formation of a protein-ligand complex with G protein-coupled receptors. This unique feature allows OR6C76 to interact with other GPCRs and G protein-coupled receptors, including GPCR subtypes that are involved in sensory perception, such as the T1R type.

Despite its importance in the sense of smell, OR6C76 is not well understood, and its potential drug-targeting properties are not yet fully defined. However, several studies have suggested that OR6C76 may be a potential drug target in the sense of smell.

One of the key reasons for the interest in OR6C76 is its potential as a drug target is its expression in the olfactory system. The olfactory system is one of the most sensitive organs in the body, and drugs that can modulate the activity of OR6C76 and its Downstream targets may have therapeutic benefits. Additionally, the fact that OR6C76 is a GPCR gene also suggests that it may be a good candidate for small molecule inhibitors, which are a common type of drug that can inhibit the activity of GPCRs.

Another potential mechanism by which OR6C76 may be a drug target is its role in the regulation of sensory perception. The Olfactory system is involved in the perception of scents, but it is also involved in the regulation of the perception of other types of sensory stimuli. For example, OR6C76 has been shown to play a role in the regulation of the perception of sweet and sour tastes. Additionally, OR6C76 may also be involved in the regulation of the perception of other types of sensory stimuli, such as texture and temperature.

Finally, OR6C76 may also be a drug target because of its potential role in the development of certain diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the build-up of neurode waste, which can lead to a range of symptoms, including cognitive decline and motor dysfunction. It is possible that OR6C76 may be involved in the development and progression of these conditions, and targeting its activity may be a potential therapeutic approach.

In conclusion, OR6C76 is a GPCR gene that is expressed in the olfactory system of the human nose. Its unique feature, as a member of the Olfactory receptor family member 6 subfamily C, makes it a potential drug target in the sense of smell. Additionally , its potential role in the regulation of sensory perception and its involvement in the development of certain diseases make it a promising candidate for further study. Further research is needed to fully understand the potential drug

Protein Name: Olfactory Receptor Family 6 Subfamily C Member 76

Functions: Odorant receptor

The "OR6C76 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR6C76 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4 | OR9G9 | OR9H1P | OR9I1 | OR9K2 | OR9Q1 | OR9Q2 | ORAI1 | ORAI2 | ORAI3 | ORC1 | ORC2 | ORC3 | ORC4